OneAscent Wealth Management’s Eli Lilly LLY Stock Holding History

OneAscent Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$317K	Sell	345 -1	-0.3%	-$1.01K	0.1%	106
2025 Q4	$372K	Sell	346 -12	-3%	-$11.5K	0.12%	89
2025 Q3	$273K	Sell	358 -1	-0.3%	-$744	0.09%	132
2025 Q2	$280K	Buy	359 +87	+32%	+$67.6K	0.1%	123
2025 Q1	$225K	Sell	272 -75	-22%	-$62.4K	0.1%	132
2024 Q4	$268K	Sell	347 -105	-23%	-$86.9K	0.11%	127
2024 Q3	$400K	Buy	+452	New	+$406K	0.15%	92
2024 Q2	–	Sell	-461	Closed	-$359K	–	139
2024 Q1	$359K	Buy	+461	New	+$328K	0.14%	106
2023 Q4	–	Sell	-444	Closed	-$238K	–	191
2023 Q3	$238K	Buy	+444	New	+$229K	0.1%	138
2023 Q1	–	Sell	-1,735	Closed	-$635K	–	186
2022 Q4	$635K	Sell	1,735 -155	-8%	-$55K	0.3%	32
2022 Q3	$611K	Sell	1,890 -118	-6%	-$37.4K	0.32%	27
2022 Q2	$651K	Sell	2,008 -16	-0.8%	-$4.8K	0.33%	31
2022 Q1	$580K	Buy	+2,024	New	+$521K	0.29%	56
2021 Q1	$390K	Sell	2,088 -4,692	-69%	-$918K	0.17%	145
2020 Q4	$1.15M	Buy	+6,780	New	+$1.01M	0.52%	28

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OneAscent Wealth Management's LLY Position: Q1 2026 in Review

OneAscent Wealth Management reduced its Eli Lilly (LLY) stake by 0.29% in Q1 2026, selling an estimated $1.01K and leaving 345 shares worth $317K. The position accounts for 0.1% of the portfolio, ranked #106.

OneAscent Wealth Management first reported a position in LLY in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.15M in Q4 2020. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

OneAscent Wealth Management held 345 shares of Eli Lilly worth $317K as of Q1 2026.
OneAscent Wealth Management sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
Eli Lilly made up 0.1% of OneAscent Wealth Management's portfolio in Q1 2026, its #106 holding.
OneAscent Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 15 quarters since.
OneAscent Wealth Management's Eli Lilly position peaked at $1.15M in Q4 2020.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on OneAscent Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.